Frontiers Lecture: Anke Henning, PhD

09/27/2019 12:00 PM - 01:00 PM
DallasTX 

Event Pass Information

Event Pass Type
Quantity
Frontiers Lecture

Event Details

Frontiers of BrainHealth Lunch Lecture Series 


The Center for BrainHealth invites scientists to share their scientific study with students and other researchers at the Frontiers of BrainHealth Lunch Lectures. The lectures are heavily science focused and are not intended for a lay audience. Lectures to be simulcast among UTD affiliated locations.

The lectures are free, but you must register to reserve your seat. Lunch is served at 11:45 AM.

Anke Henning, PhD - Imaging Human Brain Metabolism Exploiting Ultra-High Field Magnetic Resonance Imaging

Dr. Henning, an expert in medical imaging technology development, has been Director of the Advanced Imaging Research Center at UT Southwestern Medical Center since January 2019.  

Today, metabolic MRI allows for noninvasive visualization of disease-related structural, functional and metabolic changes in the human brain, spinal cord and heart. It has become an important tool for neurophysiological research. Dr. Henning has developed novel magnetic resonance imaging methods she will discuss at the lecture. 

In vivo magnetic resonance spectroscopy – the major metabolic MRI method - has evolved during the last 25 years in terms of localization quality and spatial resolution, acquisition speed, artifact suppression, number of detectable metabolites and quantification precision and has benefited from the significant increase of magnetic field strength that recently became available for in vivo investigations.

Her specific expertise is in ultra-high field magnetic imaging technology, magnetic resonance spectroscopy and non-proton imaging. She also directs clinical research with respect to brain imaging in psychiatric disorders, spinal cord imaging in traumatic injury and imaging of the human heart. At UT Southwestern, Dr. Henning has expanded her research interests to include imaging glioblastoma with the ultimate goal of enhancing the treatment of this otherwise challenging malignancy.

She obtained a master’s degree in physics from the Technical University of Chemnitz in Germany and her Ph.D. in physics from the Swiss Federal Institute of Technology in Zurich (also known as Eidgenössische Technische Hochschule or ETH). She remained at the ETH for postdoctoral training and then was a visiting scientist in the Department of Radiology at the University Medical Center in Utrecht, the Netherlands. In 2012, she joined the Max Planck Institute for Biological Cybernetics in Tübingen, Germany, as a Research Group Leader and in 2017 was made a full Professor of Medical Physics at the Ernst-Moritz Arndt University in Greifswald, Germany.